Explore All Access
Check if your research matches the topics covered in Breast Cancer: Targets and Therapy?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Breast Cancer: Targets and Therapy : Impact Factor & More
eISSN: 1179-1314pISSN: 1179-1314
Open AccessShare this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Breast Cancer: Targets and Therapy Key Metrics
CiteScore 
5.9
Impact Factor
< 5
SJR
Q1Oncology
SNIP
1.51
Time to Publish
View Chart Mo
Topics Covered on Breast Cancer: Targets and Therapy
Breast cancer
Overall survival
Metastatic breast cancer
Cross-sectional study
Breast cancer screening
Trastuzumab
Triple-negative breast cancer
Pathological response
Molecular pathology
Quality of life
Mastectomy
Ataxia telangiectasia mutated
Breast cancer cells
Eribulin
Hormone therapy
Progesterone receptor
Axillary ultrasound
Standard therapy
Immunohistochemistry
Breast examination
Breast Cancer: Targets and Therapy Journal Specifications
| Overview | |
| Publisher | DOVE MEDICAL PRESS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2836 |
| Publication Time | 16 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2009 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
One subscription packed with expert publication services and AI tools to get you published
Brought to you by 
Journal Selection Service
Benefit from our experts' recommendations of 3-5 best-suited journals, accompanied by a detailed Journal Selection report explaining the choices. Make informed decisions.
Journal Submission Service
Streamline your submission process with meticulous manuscript formatting to meet journal guidelines, crafting a tailored cover letter for the editor, and hassle-free account creation and submission
Bundle of AI tools for your research needs
Journal Finder, Paperpal, R Discovery, MindTheGraph and more
Time to Publish
% of papers by time taken from submission to publication
0 to 3 months27%
4 to 6 months70%
7 to 9 months3%
Above 9 months0%
Did you find this useful?
Planning to publish in Breast Cancer: Targets and Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Breast Cancer: Targets and Therapy
ZNF217 Gene Copy Number as a Marker of Response to Standard Therapy Drugs According to ERα Status in Breast Cancer.
- 1 Mar 2024
- Breast cancer (Dove Medical Press)
Clinical Outcomes of Patients with HER2 Positive Metastatic Breast Cancer to the Brain, with First-Line Trastuzumab, Pertuzumab and Chemotherapy, in a Real-World Setting.
- 1 Mar 2024
- Breast cancer (Dove Medical Press)
An Analysis of Preoperative Inflammatory Indicators That Influence the Drainage Tube Retention Time in Patients with Breast Cancer Surgery.
- 1 Mar 2024
- Breast cancer (Dove Medical Press)
The Role of Ki-67 in HR+/HER2- Breast Cancer: A Real-World Study of 956 Patients.
- 1 Mar 2024
- Breast cancer (Dove Medical Press)
GNPNAT1 is a Biomarker That Predicts a Poor Prognosis of Breast Cancer.
- 1 Mar 2024
- Breast cancer (Dove Medical Press)
Antibody-Drug Conjugates in Breast Cancer: A Comprehensive Review of How to Selectively Deliver Payloads.
- 1 Feb 2024
- Breast cancer (Dove Medical Press)
ZNF217 Gene Copy Number as a Marker of Response to Standard Therapy Drugs According to ERα Status in Breast Cancer.
- 1 Mar 2024
- Breast cancer (Dove Medical Press)
Clinical Outcomes of Patients with HER2 Positive Metastatic Breast Cancer to the Brain, with First-Line Trastuzumab, Pertuzumab and Chemotherapy, in a Real-World Setting.
- 1 Mar 2024
- Breast cancer (Dove Medical Press)
An Analysis of Preoperative Inflammatory Indicators That Influence the Drainage Tube Retention Time in Patients with Breast Cancer Surgery.
- 1 Mar 2024
- Breast cancer (Dove Medical Press)
The Role of Ki-67 in HR+/HER2- Breast Cancer: A Real-World Study of 956 Patients.
- 1 Mar 2024
- Breast cancer (Dove Medical Press)
GNPNAT1 is a Biomarker That Predicts a Poor Prognosis of Breast Cancer.
- 1 Mar 2024
- Breast cancer (Dove Medical Press)
Antibody-Drug Conjugates in Breast Cancer: A Comprehensive Review of How to Selectively Deliver Payloads.
- 1 Feb 2024
- Breast cancer (Dove Medical Press)
Compare Similar Journals with Breast Cancer: Targets and Therapy
Select Journals to Compare with Breast Cancer: Targets and Therapy
Total journals - 8
You can select up to 3 Journals at a time
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
Annals of Oncology
Publisher: ELSEVIER
Breast Cancer Research and Treatment
Publisher: SPRINGER
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Breast Cancer
Publisher: SPRINGER JAPAN KK
BMC Cancer
Publisher: BMC
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
Cancers
Publisher: MDPI
0 Journals Selected to compare with
Breast Cancer: Targets and Therapy
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Breast Cancer: Targets and Therapy
How long has Breast Cancer: Targets and Therapy been actively publishing? 
Breast Cancer: Targets and Therapy has been in operation since 2009 till date.
What is the publishing frequency of Breast Cancer: Targets and Therapy?
Breast Cancer: Targets and Therapy published with a Continuous publication frequency.
How many articles did Breast Cancer: Targets and Therapy publish last year?
In 2023, Breast Cancer: Targets and Therapy publsihed 65 articles.
What is the eISSN & pISSN for Breast Cancer: Targets and Therapy?
For Breast Cancer: Targets and Therapy, eISSN is 1179-1314 and pISSN is 1179-1314.
What is Citescore for Breast Cancer: Targets and Therapy?
Citescore for Breast Cancer: Targets and Therapy is 5.9.
What is SNIP score for Breast Cancer: Targets and Therapy?
SNIP score for Breast Cancer: Targets and Therapy is 1.51.
What is the SJR for Breast Cancer: Targets and Therapy?
SJR for Breast Cancer: Targets and Therapy is Q1.
Who is the publisher of Breast Cancer: Targets and Therapy?
DOVE MEDICAL PRESS LTD is the publisher of Breast Cancer: Targets and Therapy.
